Evaluation and Treatment of Memory Loss in Young Adults

Initial Clinical Assessment

• The American Academy of Child and Adolescent Psychiatry recommends immediately reviewing all medications for anticholinergic burden, as these are a common and reversible cause of memory impairment in young adults 1
• High-risk medications for memory impairment include first-generation antihistamines, muscle relaxants, oxybutynin, and tricyclic antidepressants 1
• Discontinue or substitute anticholinergic medications whenever possible, as cognitive effects can be reversed with medication changes 1
• Administer validated screening instruments, such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), to objectively document impairment 2, 3, 4
• Focus testing on short-term memory and new knowledge acquisition 5, 6

Comprehensive Laboratory Evaluation

• Essential laboratory tests include complete blood count with differential, comprehensive metabolic panel, thyroid-stimulating hormone (TSH), vitamin B12 level, and hemoglobin A1C 5, 6, 7
• Urinalysis and urine toxicology screen can help identify infections and substance use 2, 5, 6

Neuroimaging

• MRI is superior to CT for identifying structural lesions that may cause memory impairment 5, 6
• Order MRI brain with and without contrast unless contraindicated 5, 6

Assess for Depression and Psychiatric Causes

• Screen for depression systematically, as it commonly presents with cognitive complaints in young adults 2, 4

Identify Specific Reversible Causes

• Common treatable etiologies in young adults include medication side effects, substance use, metabolic disturbances, infections, and autoimmune encephalitis 1, 2, 5, 6, 7

Functional Impact Assessment

• Evaluate the impact on activities of daily living (ADLs) and instrumental ADLs 8, 2
• Assess work performance, social relationships, and independent living capacity 8, 2

Treatment Approach

• Discontinue offending medications and substitute with non-anticholinergic alternatives 1
• Treat underlying medical conditions, such as thyroid disease, B12 deficiency, and diabetes 5, 6, 7
• Manage depression with appropriate antidepressants, avoiding tricyclics due to anticholinergic effects 2, 4

Follow-Up Strategy

• Schedule a follow-up visit within 2-4 weeks to review test results and assess response to interventions 8
• Repeat cognitive testing at follow-up to document stability, improvement, or decline 8, 5, 6